US Emergency Department Visits for Acute Harms From Prescription Opioid Use, 2016–2017
Datos Bibliográficos
Objectives. To estimate the number of US emergency department visits for prescription opioid harms by patient characteristics, intent, clinical manifestations, and active ingredient. Methods. We used data from medical record–based surveillance from a nationally representative 60-hospital sample. Results. Based on 7769 cases, there were 267 020 estimated emergency department visits annually (95% confidence interval [CI] = 209 833, 324 206) for prescription opioid harms from 2016 to 2017. Nearly half of visits (47.6%; 95% CI = 40.8%, 54.4%) were attributable to nonmedical opioid use, 38.9% (95% CI = 32.9%, 44.8%) to therapeutic use, and 13.5% (95% CI = 11.0%, 16.0%) to self-harm. Co-implication with other pharmaceuticals and concurrent illicit drug and alcohol use were common; prescription opioids alone were implicated in 31.5% (95% CI = 27.2%, 35.8%) of nonmedical use visits and 19.7% (95% CI = 15.7%, 23.7%) of self-harm visits. Unresponsiveness or cardiorespiratory failure (30.0%) and altered mental status (35.7%) were common in nonmedical use visits. Gastrointestinal effects (30.4%) were common in therapeutic use visits. Oxycodone was implicated in more than one third of visits across intents. Conclusions. Morbidity data can help target interventions, such as dispensing naloxone to family and friends of those with serious overdose, and screening and treatment of substance use disorder when opioids are prescribed long-term
(+)-Naloxone · Confidence interval · Emergency department · Medical prescription · Opioid · Oxycodone · Psychiatry · Psychological intervention · Emergency Medicine · HIV, Drug Use, Sexual Risk · Internal Medicine · Medicine · Opioid Use Disorder Treatment · Pharmacology · Suicide and Self-Harm Studies
Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants — United States, 2015–2016
Mortality risk during and after opioid substitution treatment
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
Language and Addiction
Evaluation and Overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (Neiss-Cades)
| Obras citantes distintas | 2 |
|---|---|
| Citas por año | 0,33 |
| Intervalo de citas | 2020 - 2022 (3) |
| Velocidad de citación | historical |
| Altamente citado | No |
| Tipos de cita | Neutras: 2 |